Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.53 |
| ▸ | MAPK8 | P45983 | 8/20 | 0.44 |
| ▸ | MAPK10 | P53779 | 6/20 | 0.44 |
| ▸ | MAPK9 | P45984 | 6/20 | 0.42 |
| ▸ | EGFR | P00533 | 4/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.42 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.42 |
| ▸ | GAK | O14976 | 1/20 | 0.42 |
| ▸ | ERN1 | O75460 | 1/20 | 0.42 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.42 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.42 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.42 |
| ▸ | LIMK2 | P53671 | 1/20 | 0.42 |
| ▸ | MYLK | Q15746 | 1/20 | 0.42 |
| ▸ | SIK3 | Q9Y2K2 | 1/20 | 0.42 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.41 |
| ▸ | GSK3A | P49840 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL559492 | 1.00 | IRAK4 (0.53) | IRAK4MAPK8MAPK10MAPK9EGFR | |
| SCHEMBL559760 | 1.00 | IRAK4 (0.53) | IRAK4MAPK8MAPK10MAPK9EGFR | |
| SCHEMBL559232 | 1.00 | IRAK4 (0.53) | IRAK4MAPK8MAPK10MAPK9EGFR | |
| SCHEMBL559759 | 1.00 | IRAK4 (0.53) | IRAK4MAPK8MAPK10MAPK9EGFR | |
| SCHEMBL559491 | 1.00 | IRAK4 (0.53) | IRAK4MAPK8MAPK10MAPK9EGFR | |
| SCHEMBL559561 | 0.94 | IRAK4 (0.46) | IRAK4MAPK8MAPK10MAPK9EGFR | |
| SCHEMBL559562 | 0.94 | IRAK4 (0.46) | IRAK4MAPK8MAPK10MAPK9EGFR | |
| SCHEMBL559063 | 0.91 | MAPK1 (0.46) | IRAK4MAPK8MAPK10MAPK9MAPK1 | |
| SCHEMBL558757 | 0.87 | MAPK1 (0.44) | IRAK4MAPK8MAPK10MAPK9MAPK1 | |
| SCHEMBL558758 | 0.87 | MAPK1 (0.44) | IRAK4MAPK8MAPK10MAPK9MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120035194-A1 | SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS | PFIZER INC. (US) | 2012-02-09 | — | — | US | disclosed |
| US-7998978-B2 | Substituted 2-amino-fused heterocyclic compounds | PFIZER INC. (US) | 2011-08-16 | — | — | US | disclosed |
| US-20100056506-A1 | SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS | PFIZER PRODUCTS INC. (US) | 2010-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035194-A1 | SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS | MAPK1, SLC5A1, ATF1 | IRAK4 545/4885MAPK8 20/4885MAPK10 32/4885 |
| US-20100056506-A1 | SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS | MAPK1, SLC5A1, ATF1 | IRAK4 545/4885MAPK8 20/4885MAPK10 32/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.